HomeDRREDDY • NSE
Dr Reddy's Laboratories Ltd
₹1,200.40
Nob 27, 3:03:57 PM GMT+5:30 · INR · NSE · Disclaimer
StockSegurong nakalista sa INMay headquarter sa IN
Nakaraang pagsara
₹1,208.65
Sakop ng araw
₹1,198.05 - ₹1,215.60
Sakop ng taon
₹1,074.00 - ₹1,421.49
Market cap
1.00T INR
Average na Volume
1.53M
P/E ratio
18.75
Dividend yield
0.67%
Primary exchange
NSE
CDP Climate Change Score
A-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(INR)Set 2024Y/Y na pagbabago
Kita
80.16B16.51%
Gastos sa pagpapatakbo
29.72B24.54%
Net na kita
12.55B-15.18%
Net profit margin
15.66-27.20%
Kita sa bawat share
15.83-11.13%
EBITDA
22.02B8.53%
Aktuwal na % ng binabayarang buwis
30.01%
Kabuuang asset
Kabuuang sagutin
(INR)Set 2024Y/Y na pagbabago
Cash at mga panandaliang investment
63.07B-7.15%
Kabuuang asset
465.96B34.27%
Kabuuang sagutin
156.67B66.79%
Kabuuang equity
309.28B
Natitirang share
833.05M
Presyo para makapag-book
3.30
Return on assets
10.24%
Return on capital
13.21%
Net change in cash
(INR)Set 2024Y/Y na pagbabago
Net na kita
12.55B-15.18%
Cash mula sa mga operasyon
9.32B-48.03%
Cash mula sa pag-invest
-19.07B-322.21%
Cash mula sa financing
16.15B329.53%
Net change in cash
6.37B1.03%
Malayang cash flow
3.92B-72.47%
Tungkol
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Itinatag
1984
Mga Empleyado
27,048
Tumuklas pa
Maaaring interesado ka sa
Nabuo ang listahang ito mula sa mga paghahanap kamakailan lang, mga sinubaybayang security, at iba pang aktibidad. Alamin pa

“As is” na ibinibigay ang lahat ng data para lang sa mga layunin sa personal na impormasyon, at hindi inilaan na maging payong pinansyal, ni hindi rin ito para sa mga layunin sa trading o investment, buwis, legal, accounting, o iba pang payo. Hindi tagapayo sa investment ang Google, ni hindi rin ito pinansyal na tagapayo at walang inihahayag na pananaw, rekomendasyon, o opinyon patungkol sa anumang kumpanyang kasama sa listahang ito o sa anumang seguridad na inisyu ng mga kumpanyang iyon. Konsultahin ang iyong broker o pampinansyal na kinatawan para ma-verify ang presyo bago magsagawa ng anumang trade. Matuto pa
Naghanap din ang mga tao ng
Search
I-clear ang paghahanap
Isara ang paghahanap
Mga app ng Google
Pangunahing menu